MedTrace Logo

Effects of Postural Education or Corrective Exercise on Forward Head Posture

NCT05321654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2022-04-11

No results posted yet for this study

Summary

This randomized control trial examined the effects of postural education or corrective exercise intervention on the craniovertebral angle (CVA) in young adults with forward head posture (FHP). The objectives were 1: to investigate whether or not a corrective exercise program (CEP) consisting of self-myofascial release (SMR) + stretching; a CEP consisting of SMR + stretching + strengthening; or postural education (PE) had an effect on the CVA; 2. to determine which intervention yielded the greatest postural enhancement if a positive effect was observed in more than one intervention. \*\[note: SMR is a technique involving the self-application of pressure to fascia and muscle tissue for the purpose of enhancing flexibility, reducing muscle soreness, and influencing muscle relaxation\]. It was hypothesized that 4 weeks after receiving either CEP intervention or PE there would be a significant change in the CVA compared to a control group; and that there would be an intervention more effective than the others for improving the CVA. The null hypotheses were: there would be no CVA change after intervention in any of the groups; and there will be no intervention more effective than another for improving the CVA.

Conditions

  • Postural; Defect

Interventions

BEHAVIORAL

Education for Behavior Modification

Please see arm description for a detailed description of the intervention

BEHAVIORAL

Corrective Exercise Program

Please see arm description for a detailed description of the intervention

Sponsors & Collaborators

  • National Academy of Sports Medicine

    collaborator UNKNOWN

  • Liberty University

    lead OTHER

Principal Investigators

  • David A Titcomb, DPT · Liberty University

  • Bridget F Melton, EdD · Concordia University Chicago

  • Theresa Miyashita, PhD · Concordia University Chicago

  • Helen W Bland, PhD · Concordia University Chicago

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-26
Primary Completion
2021-11-04
Completion
2021-11-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05321654 on ClinicalTrials.gov